Get tips on talking to your doctor about changing your CML treatment

Meet Your Guide
photo of man
Hans Loland
Advocate

Hans Loland was in shock after his CML diagnosis in 2008. A blood test and bone marrow biopsy confirmed his doctor’s suspicions. His leukemia cells proved resistant to several standard treatments, so he enrolled in a clinical trial. Today, he is in remission and shares his experience with others.

Show Sources

SOURCES:

Hans Loland, 56, chronic myeloid leukemia patient advocate, Woodinville, WA. 

Cancer.net: “Leukemia: Chronic myeloid – CML: Types of Treatment.” 

Leukemia and Lymphoma Society: “Chronic Myeloid Leukemia,” “Chronic Myeloid Leukemia – Treatment by Phase of CML,” “Understanding the Value of PCR Testing in the Management of CML, a Rare Blood Cancer,” “Tyrosine Kinase Inhibitors.” 

American Cancer Society: “Treating Chronic Myeloid Leukemia,” “Living as a Chronic Myeloid Leukemia Survivor.”

National Cancer Society: “Chronic Myelogenous Leukemia Treatment.”

Leukemia: “Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors.”